首页|DSA联合动态增强CT定量分析肝癌HAIC的疗效

DSA联合动态增强CT定量分析肝癌HAIC的疗效

扫码查看
目的:探讨DSA联合动态增强CT定量分析和评估肝癌经肝动脉灌注化疗(HAIC)的疗效。方法:临床诊断为原发性肝癌患者50例,均行3次以上HAIC治疗。根据第1次及第3次HAIC治疗前1周内的增强CT,按照改良实体瘤疗效评价标准分为疗效良好组(CR+PR)和疗效不佳组(SD+PD),比较两组治疗前和2次HAIC治疗后DSA造影肝癌的血流动力学参数[染色达峰时间(TP)、峰值密度(PV)、时间-密度曲线上升支斜率(SU)]及CT增强扫描肝癌各期CT值的变化,并进行敏感性分析。对有统计学差异的指标进行Logistic回归分析和ROC曲线分析,以评估判断肝癌HAIC疗效的效能。结果:治疗前,两组间CT值及DSA指标无显著差异(P>0。05)。所有患者均成功完成2次HAIC治疗。第3次HAIC治疗前1周的增强CT,疗效良好组的动脉期和静脉期CT值相比于治疗前显著降低(P<0。05),延时期CT值无显著差异(P>0。05)。第3次HAIC时DSA造影肝癌的血流动力学参数PV与SU显著降低,TP显著延长(P<0。05)。疗效不佳组各项指标差异不显著。回归分析显示,动脉期CT值和DSA造影SU值与疗效显著相关。ROC曲线结果显示,动脉期CT值和SU值是判断疗效的有效指标。结论:DSA造影的SU值和动态增强CT的CT值能够客观地反映HAIC后肝癌的血供变化,且与HAIC疗效相关,可作为评估HAIC疗效的影像学依据。
Efficacy evaluation of hepatic arterial infusion chemotherapy for liver cancer through quantitative analysis of digital subtraction angiography and dynamic contrast-enhanced CT
Objective To investigate the value of the quantitative analysis of digital subtraction angiography(DSA)and dynamic contrast-enhanced CT in evaluating the efficacy of hepatic artery infusion chemotherapy(HAIC)for liver cancer.Methods Fifty patients who were clinically diagnosed with primary liver cancer and treated with HAIC at least 3 times were enrolled in the study.Based on the enhanced CT scans taken within 1 week before the 1st and 3rd HAIC,patients were divided into good response group(CR+PR)and poor response group(SD+PD)according to the modified response evaluation criteria in solid tumor.The hemodynamic parameters[time to peak(TP),peak density(PV),and slope of the rising edge of the time-density curve(SU)]of liver cancer on DSA before treatment and after two HAIC,as well as the changes in the CT values of liver cancer in each phase of CT enhancement were compared,and then sensitivity analysis was conducted.Significant indicators were further analyzed with Logistic regression and ROC curve to assess their efficacies in evaluating HAIC response in liver cancer.Results The differences in pre-treatment CT values and DSA indicators between two groups were trivial(P>0.05).All patients successfully completed HAIC twice.The enhanced CT taken 1 week before the 3rd HAIC showed reductions in the arterial-and venous-phase CT values in good response group(P<0.05),while no significant difference was found in the delayed-phase CT value(P>0.05).At the 3rd HAIC,DSA angiography demonstrated significant reductions in PV and SU,and a significant prolongation of TP in good response group(P<0.05);while there were no significant differences in various indicators in poor response group.Regression analysis showed that arterial-phase CT values and DSA angiography SU were significantly correlated with therapeutic efficacy.ROC curve results indicated that arterial-phase CT values and SU were effective indicators for evaluating therapeutic efficacy.Conclusion The SU from DSA angiography and the CT values from dynamic contrast-enhanced CT which can objectively reflect the changes in blood supply of liver cancer after HAIC and are associated with HAIC efficacy can serve as radiological evidence for evaluating HAIC response.

hepatic artery infusion chemotherapyprimary liver cancerefficacy analysisdigital subtraction angiographydynamic contrast-enhanced CT

高瑞晖、陈勇、曾庆乐、庞桦进、林坚、郝金华

展开 >

中山火炬开发区人民医院放射医学中心,广东中山 528437

南方医科大学南方医院血管与介入科,广东广州 510515

经肝动脉灌注化疗 原发性肝癌 疗效分析 数字减影血管造影 动态增强CT

中山市社会公益科技研究项目广东省科技计划项目

2022B11142012B010200027

2024

中国医学物理学杂志
南方医科大学,中国医学物理学会

中国医学物理学杂志

CSTPCD
影响因子:0.483
ISSN:1005-202X
年,卷(期):2024.41(7)